Copyright
        ©2009 The WJG Press and Baishideng.
    
    
        World J Gastroenterol. Jul 7, 2009; 15(25): 3086-3098
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3086
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3086
            Table 1 Main AHF animal models in different species
        
    | Animal model | Species | Advantages/disadvantages | 
| Surgical | ||
| Total/partial hepatectomy | Pig, dog, rabbit, rat, mouse | Hepatic encephalopathy; reproducible/no reversibility; no long-term survival | 
| Total/partial devascularization | Pig, dog, rabbit, rat | Hepatic encephalopathy; reproducible/no reversibility; no long-term survival | 
| Chemical | ||
| Acetaminophen | Pig, dog, rabbit, rat, mouse | Hepatic encephalopathy; no hazard/non-reproducible; variable interval between damage and death; species and age variability | 
| Amanitin | Pig | Hepatic encephalopathy; specific toxic effects; large animal | 
| Azoxymethane | Mouse | Hepatic encephalopathy; reproducible/small size; hazard | 
| Carbon tetrachloride | Pig, rabbit, rat, mouse | Hepatic encephalopathy/non reproducible; extrahepatic toxicity; small time window before death | 
| Concanavalin A | Rat, mouse | Hepatic encephalopathy/small size | 
| Galactosamine | Pig, dog, rabbit, rat, mouse | Hepatic encephalopathy; biochemical markers/non-reproducible; hazard; variable interval between damage and death; species differences | 
| Lipopolysaccharide | Rat, mouse | Hepatic encephalopathy/non-reproducible; small size; hazard; small time window before death | 
| Thioacetamide | Rabbit, rat, mouse | Hepatic encephalopathy; reproducible; large time window before death/hazard | 
| Viral | ||
| Rabbit hemorrhagic disease | Rabbit | Hepatic encephalopathy; reproducible; no hazard | 
            Table 2 Main criteria for an AHF animal model (according to Terblanche and Hickman (1991)
        
    | Reversibility | Suitable treatment may reverse and improve survival | 
| Reproducibility | Reproducible end-points are required to standardize the model | 
| Death from liver failure | Should reflect biochemical, histological and clinical changes including death from AHF | 
| Therapeutic window | Time for treatment should be available between insult and death | 
| Adequate animal size | Size large enough to allow blood and tissue analysis to take place serially | 
| Minimal hazard to personnel | Minimum risk for operators and associated staff | 
- Citation: Tuñón MJ, Alvarez M, Culebras JM, González-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 2009; 15(25): 3086-3098
- URL: https://www.wjgnet.com/1007-9327/full/v15/i25/3086.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3086

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        